BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18259721)

  • 1. Molecular and cellular aspects of sepsis-induced immunosuppression.
    Wang TS; Deng JC
    J Mol Med (Berl); 2008 May; 86(5):495-506. PubMed ID: 18259721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte Immunosuppression and Dysfunction Contributing to Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS).
    Bergmann CB; Beckmann N; Salyer CE; Crisologo PA; Nomellini V; Caldwell CC
    Shock; 2021 Jun; 55(6):723-741. PubMed ID: 33021569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis of abdominal sepsis.
    Weber GF; Swirski FK
    Langenbecks Arch Surg; 2014 Jan; 399(1):1-9. PubMed ID: 24121723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.
    Cao C; Yu M; Chai Y
    Cell Death Dis; 2019 Oct; 10(10):782. PubMed ID: 31611560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked alterations of neutrophil functions during sepsis-induced immunosuppression.
    Demaret J; Venet F; Friggeri A; Cazalis MA; Plassais J; Jallades L; Malcus C; Poitevin-Later F; Textoris J; Lepape A; Monneret G
    J Leukoc Biol; 2015 Dec; 98(6):1081-90. PubMed ID: 26224052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis.
    Nedeva C
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.
    McBride MA; Patil TK; Bohannon JK; Hernandez A; Sherwood ER; Patil NK
    Front Immunol; 2020; 11():624272. PubMed ID: 33613563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia.
    Bouras M; Asehnoune K; Roquilly A
    Front Immunol; 2018; 9():2590. PubMed ID: 30483258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression.
    Ren C; Yao RQ; Zhang H; Feng YW; Yao YM
    J Neuroinflammation; 2020 Jan; 17(1):14. PubMed ID: 31924221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.
    Denstaedt SJ; Singer BH; Standiford TJ
    Front Immunol; 2018; 9():2446. PubMed ID: 30459764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of pro-and anti-inflammatory host responses.
    van der Poll T; van Zoelen MAD; Wiersinga WJ
    Contrib Microbiol; 2011; 17():125-136. PubMed ID: 21659750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dendritic cells in sepsis: an approach to post-infectious immunosuppression].
    Sirgo G; Claramonte R; Chánovas M; Esteban F; Forcadell I; Luna J; Masdeu G; Ramón Vázquez J; Artigas A
    Med Intensiva; 2010 Nov; 34(8):559-66. PubMed ID: 20034705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of immune cell functions during post-septic immunosuppression.
    Carson WF; Cavassani KA; Dou Y; Kunkel SL
    Epigenetics; 2011 Mar; 6(3):273-83. PubMed ID: 21048427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding the potential role of regulatory T cells in sepsis-induced immunosuppression.
    Huang S; Liu D; Han L; Deng J; Wang Z; Jiang J; Zeng L
    Eur J Immunol; 2024 May; 54(5):e2350730. PubMed ID: 38430202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin1 Targeting Reverses Innate and Adaptive Immune Tolerance in Septic Mice.
    Martin AN; Alexander-Miller M; Yoza BK; Vachharajani V; McCall CE
    J Immunol Res; 2018; 2018():2402593. PubMed ID: 30069485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.
    McPeak MB; Youssef D; Williams DA; Pritchett CL; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2017 Aug; 102(2):191-200. PubMed ID: 28476751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
    Hotchkiss RS; Monneret G; Payen D
    Nat Rev Immunol; 2013 Dec; 13(12):862-74. PubMed ID: 24232462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.
    Rimmelé T; Payen D; Cantaluppi V; Marshall J; Gomez H; Gomez A; Murray P; Kellum JA;
    Shock; 2016 Mar; 45(3):282-91. PubMed ID: 26529661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic and metabolic programming of innate immunity in sepsis.
    Vachharajani V; McCall CE
    Innate Immun; 2019 Jul; 25(5):267-279. PubMed ID: 30997862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.